NCT04069468

.css-1gu7o1h p{color:#FFFFFF;font-weight:600;font-size:1rem;}.css-1gu7o1h .typo{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;}.css-1hgicv7{box-sizing:border-box;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;}.css-1hgicv7 p{color:#FFFFFF;font-weight:600;font-size:1rem;}.css-1hgicv7 .typo{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;}

JavaScript is currently disabled in your browser. For the best experience, please enable JavaScript to enjoy full website functionality. Thank you!

Steps to Enable JavaScript

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

About the study

The purpose of this registry study is to gather effectiveness, QoL, safety and procedural information on TheraSphere® for the treatment of participants with Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (iCC) and liver metastases for colon cancer (mCRC) in real world clinical practice settings in France.

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

EXCLUSION CRITERIA

Inclusion:

Participant has received a reimbursed dose of TheraSphere®
Participant does not oppose to the collection of his/her medical personal data

Exclusion:

Participant has opposed to data collection
Participant has not received a reimbursed dose of TheraSphere® (free of charge dose)

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Call 33 630 579 149

Email Study Center

Study Details

Contition

Hepatocellular Carcinoma

Age (in years)

18+

Participants Needed

1247

Est. Completion Date

Dec 31, 2024

Treatment Type

OBSERVATIONAL

Sponsor

Boston Scientific Corporation

ClinicalTrials.gov NCT Identifier

NCT04069468

Study Number

BTG-007996-01

Understanding Clinical Trials

Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?